Skip to content

Talent Aortic Cuff Stent Graft System Compassionate Use Registry

Compassionate Use of the TALENT Aortic Cuff in the Treatment of Patients Previously Treated With the AneuRx Stent Graft System With Sub-Optimal Stent Graft Outcomes

Status
NO_LONGER_AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT00604643
Enrollment
Unknown
Registered
2008-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysms

Keywords

Abdominal Aneurysm, Endovascular Aortic Repair (EVAR), Endovascular Stent Graft, Endograft

Brief summary

An evaluation of the TALENT Aortic Cuff in patients with existing AneuRx stent grafts who have experienced sub-optimal stent graft outcomes and are not deemed suitable candidates for treatment with an AneuRx Aortic Cuff.

Detailed description

The primary purpose of this registry is to provide an endovascular means of treatment for those patients experiencing a sub-optimal outcome related to the implanted AneuRx bifurcated stent graft and who are not deemed suitable candidates for treatment with an AneuRx Aortic Cuff. A sub-optimal outcome is defined as either a Type I or Type III endoleak and/or an inadequate seal zone (\< 1 cm). For Registry purposes, a Type III endoleak will be defined as a proximal modular endoleak.

Interventions

DEVICETALENT Aortic Cuff Abdominal Stent Graft

Endovascular Aneurysm Repair

Sponsors

Medtronic Cardiovascular
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient \>= 18 years of age * Patient has a serious disease or condition * No generally acceptable alternative for treating patient is available * Patient has had the AneuRx stent graft system implanted \>= 30 days * Patient has suboptimal outcome with the AneuRx stent graft system as evidenced by one or more of the following: * Type I endoleak * Type III endoleak (Proximal, modular) * Loss of seal zone * Proximal aortic neck diameter \>= 14mm and \<= 30mm * Angle between axis of the suprarenal aorta and aneurysm neck is \<= 60 degrees * Patient is able and willing to be available for 12,24,26,48 and 60 months post-procedure

Exclusion criteria

* Patient is pregnant of lactating * Arterial access cannot be crossed with a delivery system * Excessive vessel tortuosity * Excessive aortic calcification * AneuRx stent graft system implanted within the last 30 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026